PRDM10 activators represent a chemical class designed to modulate the activity of the PRDM10 protein. PRDM10 is part of a larger family of PR domain-containing proteins, which are known to play roles in cellular differentiation, development, and cancer. Activators of PRDM10 can influence its function by binding directly or indirectly, leading to alterations in its intrinsic activities and, consequently, its downstream effects.
The activation of PRDM10, much like other proteins of its family, is intertwined with a series of intricate signaling pathways that orchestrate cellular events. Chemicals such as Phorbol Myristate Acetate (PMA) work by activating Protein Kinase C (PKC), a critical intermediary in many signaling cascades. PKC activation can relay signals to proteins like PRDM10, influencing their activity and cellular outcomes. Similarly, Ionomycin, which raises intracellular calcium levels, can impact PRDM10 function by modulating calcium-dependent pathways. Another notable compound is Forskolin, which boosts adenylate cyclase activity, causing a surge in cAMP levels. Elevated cAMP can then affect cAMP-dependent pathways that interact with or regulate PRDM10. The specifics of how these chemicals impact PRDM10, whether direct or via broader signaling pathways, highlight the complexity of intracellular communication and the nuanced roles that individual proteins play within this vast network.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC) which is known to be involved in various cellular pathways, including those influencing transcriptional regulators. PRDM10, being a transcriptional regulator, may be influenced by PKC activation. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin elevates intracellular calcium levels, affecting various calcium-dependent pathways that might influence transcriptional activity, possibly modulating PRDM10's function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to elevated cAMP levels and potentially influencing cAMP-dependent pathways that could modulate PRDM10. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound affects DNA methylation, which can influence the activity of transcriptional regulators like PRDM10. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog which might modulate cAMP-dependent pathways affecting transcriptional regulators such as PRDM10. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor which can impact chromatin accessibility and thereby influence transcriptional regulators, potentially modulating PRDM10. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A sirtuin activator, influencing chromatin modifications, which may impact transcriptional regulators including PRDM10. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Acts as an HDAC inhibitor, potentially influencing transcriptional activity, and could affect PRDM10 function. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
An HDAC inhibitor that can influence transcriptional activity and could modulate PRDM10. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor which could stabilize PRDM10 by preventing its degradation. | ||||||